- Home
- TCBX vs THRD Comparison
TCBX vs THRD Comparison
Compare TCBX & THRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCBX
- THRD
- Stock Information
- Founded
- TCBX 2008
- THRD 2019
- Country
- TCBX United States
- THRD United States
- Employees
- TCBX N/A
- THRD N/A
- Industry
- TCBX Banks
- THRD Biotechnology: Pharmaceutical Preparations
- Sector
- TCBX Finance
- THRD Health Care
- Exchange
- TCBX Nasdaq
- THRD Nasdaq
- Market Cap
- TCBX 473.0M
- THRD 513.2M
- IPO Year
- TCBX 2021
- THRD 2022
- Fundamental
- Price
- TCBX $34.25
- THRD $10.84
- Analyst Decision
- TCBX Buy
- THRD Strong Buy
- Analyst Count
- TCBX 4
- THRD 3
- Target Price
- TCBX $25.50
- THRD $20.33
- AVG Volume (30 Days)
- TCBX 85.4K
- THRD 259.3K
- Earning Date
- TCBX 01-23-2025
- THRD 11-07-2024
- Dividend Yield
- TCBX N/A
- THRD N/A
- EPS Growth
- TCBX 38.69
- THRD N/A
- EPS
- TCBX 2.56
- THRD N/A
- Revenue
- TCBX $158,911,000.00
- THRD N/A
- Revenue This Year
- TCBX N/A
- THRD N/A
- Revenue Next Year
- TCBX $8.54
- THRD N/A
- P/E Ratio
- TCBX $13.35
- THRD N/A
- Revenue Growth
- TCBX 17.73
- THRD N/A
- 52 Week Low
- TCBX $18.00
- THRD $8.08
- 52 Week High
- TCBX $37.65
- THRD $16.94
- Technical
- Relative Strength Index (RSI)
- TCBX 46.12
- THRD 40.49
- Support Level
- TCBX $36.07
- THRD $10.53
- Resistance Level
- TCBX $37.37
- THRD $11.84
- Average True Range (ATR)
- TCBX 1.36
- THRD 0.86
- MACD
- TCBX -0.43
- THRD -0.07
- Stochastic Oscillator
- TCBX 26.41
- THRD 17.60
About TCBX Third Coast Bancshares Inc.
Third Coast Bancshares Inc is a bank holding company. It focuses on providing commercial banking solutions to small and medium-sized businesses and professionals with operations in its markets. The bank operates eleven branches in the Greater Houston, Dallas-Fort Worth, and Austin-San Antonio markets, and one branch in Detroit, Texas. The company has one segment, community banking, it generates most of its revenue from interest on loans, customer service, and loan fees.
About THRD Third Harmonic Bio Inc.
Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.